Literature DB >> 29110582

Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand.

Sunitta Saensa-Ard1, Saman Leuangwattanawanit2, Laddawan Senggunprai1,3, Nisana Namwat1,4, Sarinya Kongpetch1,3, Yaovalux Chamgramol2, Watcharin Loilome1,4, Walaiporn Khansaard1, Apinya Jusakul1,5, Auemduan Prawan1,3, Chawalit Pairojkul1,2, Narong Khantikeo1,6, Puangrat Yongvanit1,4, Veerapol Kukongviriyapan1,3.   

Abstract

Cholangiocarcinoma is a rare type of cancer which is an increasingly discernible health threat. The disease is usually very difficult in diagnosis and various treatment modalities are typically not effective. Cholangiocarcinoma is a complex and very heterogeneous malignancy characterized by tumor location, different risk factors, molecular profiling, and prognosis. Cancer cell lines represent an important tool for investigation in various aspects of tumor biology and molecular therapeutics. We established two cell lines, KKU-452 and KKU-023, which were derived from patients residing in the endemic area of liver fluke infection in Thailand. Both of tumor tissues have gross pathology of perihilar and intrahepatic mass-forming cholangiocarcinoma. Two cell lines were characterized for their biological, molecular and genetic properties. KKU-452 and KKU-023 cells are both adherent cells with epithelium morphology, but have some differences in their growth pattern (a doubling time of 17.9 vs 34.8 h, respectively) and the expression of epithelial bile duct markers, CK7 and CK19. Cytogenetic analysis of KKU-452 and KKU-023 cells revealed their highly complex karyotypes; hypertriploid and hypotetraploid, respectively, with multiple chromosomal aberrations. Both cell lines showed mutations in p53 but not in KRAS. KKU-452 showed a very rapid migration and invasion properties in concert with low expression of E-cadherin and high expression of N-cadherin, whereas KKU-023 showed opposite characters. KKU-023, but not KKU-452, showed in vivo tumorigenicity in xenografted nude mice. Those two established cholangiocarcinoma cell lines with unique characters may be valuable for better understanding the process of carcinogenesis and developing new therapeutics for the patients.

Entities:  

Keywords:  Cholangiocarcinoma; Opisthorchis viverrini; cell line; liver fluke

Mesh:

Year:  2017        PMID: 29110582     DOI: 10.1177/1010428317725925

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  13 in total

1.  Cucurbitacin B Diminishes Metastatic Behavior of Cholangiocarcinoma Cells by Suppressing Focal Adhesion Kinase.

Authors:  Putthaporn Kaewmeesri; Veerapol Kukongviriyapan; Auemduan Prawan; Sarinya Kongpetch; Laddawan Senggunprai
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

Review 2.  Development and Characterization of Human Primary Cholangiocarcinoma Cell Lines.

Authors:  Abdulkadir Isidan; Ali Yenigun; Daiki Soma; Eric Aksu; Kevin Lopez; Yujin Park; Arthur Cross-Najafi; Ping Li; Debjyoti Kundu; Michael G House; Sanjukta Chakraborty; Shannon Glaser; Lindsey Kennedy; Heather Francis; Wenjun Zhang; Gianfranco Alpini; Burcin Ekser
Journal:  Am J Pathol       Date:  2022-05-28       Impact factor: 5.770

3.  PRIMA-1MET Induces Cellular Senescence and Apoptotic Cell Death in Cholangiocarcinoma Cells.

Authors:  Chayanit Piyawajanusorn; Yingpinyapat Kittirat; Prakasit Sa-Ngiamwibool; Attapol Titapun; Watcharin Loilome; Nisana Namwat
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

4.  The Effect of the EGFR - Targeting Compound 3-[(4-Phenylpyrimidin-2-yl) Amino] Benzene-1-Sulfonamide (13f) against Cholangiocarcinoma Cell Lines.

Authors:  Papavee Samatiwat; Lueacha Tabtimmai; Prapasiri Suphakun; Nattanan Jiwacharoenchai; Borvorrnvat Toviwek; Veerapol Kukongviriyapan; M Paul Gleeson; Kiattawee Choowongkomon
Journal:  Asian Pac J Cancer Prev       Date:  2021-02-01

5.  Bioinformatic Prediction of Novel Signaling Pathways of Apoptosis-inducing Factor, Mitochondrion-associated 3 (AIFM3) and Their Roles in Metastasis of Cholangiocarcinoma Cells.

Authors:  Daraporn Chua-On; Tanakorn Proungvitaya; Anchalee Techasen; Temduang Limpaiboon; Sittiruk Roytrakul; Doungdean Tummanatsakun; Norie Araki; Siriporn Proungvitaya
Journal:  Cancer Genomics Proteomics       Date:  2022 Jan-Feb       Impact factor: 4.069

6.  In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines.

Authors:  Hasaya Dokduang; Wassana Jamnongkarn; Bundit Promraksa; Manida Suksawat; Sureerat Padthaisong; Malinee Thanee; Jutarop Phetcharaburanin; Nisana Namwat; Sakkarn Sangkhamanon; Attapol Titapun; Narong Khuntikeo; Poramate Klanrit; Watcharin Loilome
Journal:  Drug Des Devel Ther       Date:  2020-06-11       Impact factor: 4.162

7.  Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway.

Authors:  Sasikamon Khophai; Malinee Thanee; Anchalee Techasen; Nisana Namwat; Poramate Klanrit; Attapol Titapun; Apiwat Jarearnrat; Prakasit Sa-Ngiamwibool; Watcharin Loilome
Journal:  Onco Targets Ther       Date:  2018-10-16       Impact factor: 4.147

8.  Establishment and Characterization of Two Novel Cholangiocarcinoma Cell Lines.

Authors:  Yanhua Zhang; Jingfeng Luo; Xue Dong; Fang Yang; Miaofeng Zhang; Juanjuan Zhao; Qiangfeng Wang; Fei Zhou; Jihong Sun; Xiaoming Yang
Journal:  Ann Surg Oncol       Date:  2019-07-29       Impact factor: 5.344

9.  Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient.

Authors:  Banchob Sripa; Wunchana Seubwai; Kulthida Vaeteewoottacharn; Kanlayanee Sawanyawisuth; Atit Silsirivanit; Worasak Kaewkong; Kanha Muisuk; Paweena Dana; Chatchai Phoomak; Worachart Lert-Itthiporn; Vor Luvira; Chawalit Pairojkul; Bin T Teh; Sopit Wongkham; Seiji Okada; Yaovalux Chamgramol
Journal:  Hum Cell       Date:  2020-03-23       Impact factor: 4.174

10.  Incidence and Outcome of Unexpected Non-Cardiac Abnormality on Cardiac Magnetic Resonance Imaging: A Report from Northeastern Thailand.

Authors:  Narumol Chaosuwannakit; Pattarapong Makarawate
Journal:  Tomography       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.